In a filing, Tandem Diabetes Care Inc revealed its PRESIDENT & CEO Sheridan John F acquired Company’s shares for reported $0.1 million on Aug 11 ’25. In the deal valued at $10.23 per share,10,000 shares were bought. As a result of this transaction, Sheridan John F now holds 106,327 shares worth roughly $1.15 million.
Then, Vosseller Leigh bought 13,720 shares, generating $149,404 in total proceeds. Upon buying the shares at $10.89, the EVP & CHIEF FINANCIAL OFFICER now owns 25,580 shares.
Before that, Kyrillos Jean-Claude bought 10,538 shares. Tandem Diabetes Care Inc shares valued at $190,966 were divested by the EVP & Chief Operating Officer at a price of $18.12 per share. As a result of the transaction, Kyrillos Jean-Claude now holds 10,538 shares, worth roughly $0.11 million.
Citigroup upgraded its Tandem Diabetes Care Inc [TNDM] rating to a Neutral from a a Sell in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who decreased its forecast for the stock in early August from “an Overweight” to “a Neutral”. Citigroup also remained covering TNDM and has decreased its forecast on July 09, 2025 with a “Sell” recommendation from previously “Neutral” rating. Truist started covering the stock on June 16, 2025. It rated TNDM as “a Hold”.
Price Performance Review of TNDM
On Friday, Tandem Diabetes Care Inc [NASDAQ:TNDM] saw its stock jump 1.50% to $10.82. Over the last five days, the stock has lost -3.65%. Tandem Diabetes Care Inc shares have fallen nearly -73.99% since the year began. Nevertheless, the stocks have fallen -69.96% over the past one year. While a 52-week high of $47.60 was reached on 01/06/25, a 52-week low of $9.98 was recorded on 08/07/25.
Levels Of Support And Resistance For TNDM Stock
The 24-hour chart illustrates a support level at 10.62, which if violated will result in even more drops to 10.43. On the upside, there is a resistance level at 11.09. A further resistance level may holdings at 11.37.
How much short interest is there in Tandem Diabetes Care Inc?
A steep rise in short interest was recorded in Tandem Diabetes Care Inc stocks on 2025-07-31, dropping by -1.01 million shares to a total of 8.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 9.75 million shares. There was a decline of -11.5%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 10, 2025 when Mizuho began covering the stock and recommended ‘”a Neutral”‘ rating along with a $20 price target.
